Rethinking Statistical Approaches to Evaluating Drug Safety
Open Access
- 1 January 2007
- journal article
- Published by Yonsei University College of Medicine in Yonsei Medical Journal
- Vol. 48 (6) , 895-900
- https://doi.org/10.3349/ymj.2007.48.6.895
Abstract
Liu JP. Yonsei Med J. 2007 Dec;48(6):895-900. https://doi.org/10.3349/ymj.2007.48.6.895Keywords
This publication has 11 references indexed in Scilit:
- Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular CausesNew England Journal of Medicine, 2007
- Sample size determination for matched-pair equivalence trials using rate ratioBiostatistics, 2006
- Tests for Equivalence Based on Odds Ratio for Matched-Pair DesignJournal of Biopharmaceutical Statistics, 2005
- Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention TrialNew England Journal of Medicine, 2005
- Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control studyThe Lancet, 2005
- Failing the Public Health — Rofecoxib, Merck, and the FDANew England Journal of Medicine, 2004
- Proving non-inferiority or equivalence of two treatments with dichotomous endpoints using exact methodsStatistical Methods in Medical Research, 2003
- Tests for equivalence or non‐inferiority for paired binary dataStatistics in Medicine, 2001
- Unconditional Exact Tests for Equivalence or Noninferiority for Paired Binary EndpointsBiometrics, 2001
- Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non‐zero risk difference or non‐unity relative riskStatistics in Medicine, 1990